Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the control of type 2 diabetes. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://tamzinwpsi010405.dm-blog.com/39094329/retaglutide-a-promising-glp-1-receptor-agonist